Scope Fluidics establishes an international Clinical Advisory Board for the BACTEROMIC system

Spotkanie

Bacteromic, part of the Warsaw Stock Exchange-listed Scope Fluidics Group, has established an international Clinical Advisory Board. This team of independent clinical experts will support the development of the Group’s most advanced project, the BACTEROMIC system. The Advisory Board, composed of specialists from the United Kingdom, Italy, and the United States, will assist Bacteromic in […]

Scope Fluidics reports positive results for the UNI FAST Panel and the PBC Panel

Laboratorium

Scope Fluidics, a Warsaw Stock Exchange-listed life science company developing innovative technologies for the medical diagnostics and healthcare market, has reported positive internal test results for two panels compatible with the “fast detection” software – the UNI FAST Panel and the PBC Panel. FAST is software used to detect bacterial growth and determine bacterial antibiotic […]

Scope Fluidics appoints transaction advisor for the BACTEROMIC system

Spotkanie

Scope Fluidics, a life science company listed on the Warsaw Stock Exchange, has signed an agreement with the renowned transaction advisor Perella Weinberg Partners, headquartered in the United States. This marks the launch of another key stage in the process of securing a global business partner for the BACTEROMIC system. The decision represents an important […]

Scope Fluidics expands cooperation in the FDA certification process for the UNI FAST Panel

Spotkanie

Scope Fluidics, a life science company listed on the Warsaw Stock Exchange, is expanding its cooperation with an advisor in the process of obtaining FDA certification for the BACTEROMIC system with the UNI FAST Panel. The purpose of this expansion is to enable its subsidiary, Bacteromic, to apply for certification directly for the extended version of the panel, which will shorten the time needed to assess […]

Scope Fluidics submits IVDR certification documentation for the BACTEROMIC system with the UNI Panel

Mężczyzna w laboratorium

Bacteromic, a subsidiary of Scope Fluidics Group listed on the Warsaw Stock Exchange, has submitted the documentation required to obtain IVDR certification for the BACTEROMIC system with the UNI Panel. Submitting the test results marks a key stage in the IVDR certification process and is essential for introducing the BACTEROMIC system to the European market. “We are consistently advancing our key projects, with […]

Meet Our Team at ADLM in Chicago

Zapowiedź spotkania

Our team is looking forward to connecting with industry leaders, innovators, and professionals from around the globe. The Association for Diagnostics & Laboratory Medicine (ADLM) Annual Meeting is a significant event for professionals in the clinical diagnostics and laboratory medicine field, formerly known as the AACC Annual Scientific Meeting & Clinical Lab Expo. This exciting event […]

Scope Fluidics after Q1 2025: Focus on Project Development

Scope Fluidics – a life-science company listed on the Warsaw Stock Exchange (GPW) that develops innovative technologies for the medical diagnostics and healthcare markets – held more than PLN 138 million in cash and cash equivalents at the close of Q1 2025. In the first quarter, the Group met the first of its strategic targets (regarding the number of projects and special-purpose vehicles) […]

European Patent Granted to Bacteromic

Sprzęt laboratoryjny

The European Patent Office has granted Bacteromic sp. z o.o. a patent entitled “Method and System for Prediction of Microorganism Growth Using Artificial Intelligence,” published under number EP 4377914 B1. The patent will take effect on May 21, 2025, upon its publication in the European Patent Bulletin. The patent grants Bacteromic exclusive rights to commercially […]

Meet us at the Advancements of Microbiology 2025 Conference – lecture, workshop

We are excited to invite you to lecture and workshop at the upcoming #AdvMicro Conference! 🗓 Monday, April 7 ⏰ 14:15 – 14:45h 📍 Topic:”FROM GLOBAL HEALTHCARE CHALLENGES TO A RAPIDLY EVOLVING MARKETPLACE:THE BACTEROMIC JOURNEY TOWARDS EXEMPLARY MARKET FIT, AND LESSONS LEARNT ALONG THE WAY” 🎤 Speaker: Piotr Garstecki, Co-founder & President Scope Fluidics   […]

We invite you to our Innovation and Pipeline Theatre / ESCMID Global 2025

We are excited to invite you to the Innovation and Pipeline Theater Session at the ESCMID Global in Vienna! 🗓 Saturday, April 12 ⏰ 14:00 – 14:20h 📍 Topic: BACTEROMIC: One system … Many comprehensive solutions 🎤 Speaker: Łukasz Richter, Bacteromic Product Manager ☕ 🍰 Refreshments to follow Visit us at our booth E80, where we will be showcasing our […]

Scope Fluidics establishes an international Clinical Advisory Board for the BACTEROMIC system.
A team of independent clinical experts will support the development of the Group's most advanced project, the BACTEROMIC system.

More information soon